Global Point-of-Care Molecular Diagnostics Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Point-of-Care Molecular Diagnostics Market Overview

• 1.1 Product Overview and Scope of Point-of-Care Molecular Diagnostics
• 1.2 Classification of Point-of-Care Molecular Diagnostics by Types
  • 1.2.1 Global Point-of-Care Molecular Diagnostics Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Point-of-Care Molecular Diagnostics Revenue Market Share by Types in 2018
  • 1.2.3 PCR-based
  • 1.2.4 Genetic Sequencing-based
  • 1.2.5 Hybridization-based
  • 1.2.6 Microarray-based
• 1.3 Global Point-of-Care Molecular Diagnostics Market by Application
  • 1.3.1 Global Point-of-Care Molecular Diagnostics Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Infectious Diseases
  • 1.3.3 Oncology
  • 1.3.4 Hematology
  • 1.3.5 Prenatal Testing
  • 1.3.6 Endocrinology
  • 1.3.7 Other
• 1.4 Global Point-of-Care Molecular Diagnostics Market by Regions
  • 1.4.1 Global Point-of-Care Molecular Diagnostics Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Point-of-Care Molecular Diagnostics Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Point-of-Care Molecular Diagnostics Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Point-of-Care Molecular Diagnostics Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Point-of-Care Molecular Diagnostics Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Point-of-Care Molecular Diagnostics Status and Prospect (2014-2024)
• 1.5 Global Market Size of Point-of-Care Molecular Diagnostics (2014-2024)

2 Company Profiles

• 2.1 Danaher Corporation
  • 2.1.1 Business Overview
  • 2.1.2 Point-of-Care Molecular Diagnostics Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Danaher Corporation Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Johnson and Johnson
  • 2.2.1 Business Overview
  • 2.2.2 Point-of-Care Molecular Diagnostics Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Johnson and Johnson Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 BioMerieux
  • 2.3.1 Business Overview
  • 2.3.2 Point-of-Care Molecular Diagnostics Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 BioMerieux Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 F. Hoffmann-La Roche AG
  • 2.4.1 Business Overview
  • 2.4.2 Point-of-Care Molecular Diagnostics Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 F. Hoffmann-La Roche AG Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Abbott Laboratories, Bayer Healthcare
  • 2.5.1 Business Overview
  • 2.5.2 Point-of-Care Molecular Diagnostics Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Abbott Laboratories, Bayer Healthcare Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Becton, Dickinson and Company
  • 2.6.1 Business Overview
  • 2.6.2 Point-of-Care Molecular Diagnostics Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Becton, Dickinson and Company Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Cepheid, Inc.
  • 2.7.1 Business Overview
  • 2.7.2 Point-of-Care Molecular Diagnostics Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Cepheid, Inc. Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Bio-Rad Laboratories, Inc.
  • 2.8.1 Business Overview
  • 2.8.2 Point-of-Care Molecular Diagnostics Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Bio-Rad Laboratories, Inc. Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)

3 Global Point-of-Care Molecular Diagnostics Market Competition, by Players

• 3.1 Global Point-of-Care Molecular Diagnostics Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Point-of-Care Molecular Diagnostics Players Market Share
  • 3.2.2 Top 10 Point-of-Care Molecular Diagnostics Players Market Share
• 3.3 Market Competition Trend

4 Global Point-of-Care Molecular Diagnostics Market Size by Regions

• 4.1 Global Point-of-Care Molecular Diagnostics Revenue and Market Share by Regions
• 4.2 North America Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
• 4.3 Europe Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
• 4.5 South America Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)

5 North America Point-of-Care Molecular Diagnostics Revenue by Countries

• 5.1 North America Point-of-Care Molecular Diagnostics Revenue by Countries (2014-2019)
• 5.2 USA Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
• 5.3 Canada Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)

6 Europe Point-of-Care Molecular Diagnostics Revenue by Countries

• 6.1 Europe Point-of-Care Molecular Diagnostics Revenue by Countries (2014-2019)
• 6.2 Germany Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
• 6.3 UK Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
• 6.4 France Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
• 6.5 Russia Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
• 6.6 Italy Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Point-of-Care Molecular Diagnostics Revenue by Countries

• 7.1 Asia-Pacific Point-of-Care Molecular Diagnostics Revenue by Countries (2014-2019)
• 7.2 China Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
• 7.3 Japan Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
• 7.4 Korea Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
• 7.5 India Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)

8 South America Point-of-Care Molecular Diagnostics Revenue by Countries

• 8.1 South America Point-of-Care Molecular Diagnostics Revenue by Countries (2014-2019)
• 8.2 Brazil Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Point-of-Care Molecular Diagnostics by Countries

• 9.1 Middle East and Africa Point-of-Care Molecular Diagnostics Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
• 9.3 UAE Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Point-of-Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)

10 Global Point-of-Care Molecular Diagnostics Market Segment by Type

• 10.1 Global Point-of-Care Molecular Diagnostics Revenue and Market Share by Type (2014-2019)
• 10.2 Global Point-of-Care Molecular Diagnostics Market Forecast by Type (2019-2024)
• 10.3 PCR-based Revenue Growth Rate (2014-2024)
• 10.4 Genetic Sequencing-based Revenue Growth Rate (2014-2024)
• 10.5 Hybridization-based Revenue Growth Rate (2014-2024)
• 10.6 Microarray-based Revenue Growth Rate (2014-2024)

11 Global Point-of-Care Molecular Diagnostics Market Segment by Application

• 11.1 Global Point-of-Care Molecular Diagnostics Revenue Market Share by Application (2014-2019)
• 11.2 Point-of-Care Molecular Diagnostics Market Forecast by Application (2019-2024)
• 11.3 Infectious Diseases Revenue Growth (2014-2019)
• 11.4 Oncology Revenue Growth (2014-2019)
• 11.5 Hematology Revenue Growth (2014-2019)
• 11.6 Prenatal Testing Revenue Growth (2014-2019)
• 11.7 Endocrinology Revenue Growth (2014-2019)
• 11.8 Other Revenue Growth (2014-2019)

12 Global Point-of-Care Molecular Diagnostics Market Size Forecast (2019-2024)

• 12.1 Global Point-of-Care Molecular Diagnostics Market Size Forecast (2019-2024)
• 12.2 Global Point-of-Care Molecular Diagnostics Market Forecast by Regions (2019-2024)
• 12.3 North America Point-of-Care Molecular Diagnostics Revenue Market Forecast (2019-2024)
• 12.4 Europe Point-of-Care Molecular Diagnostics Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Point-of-Care Molecular Diagnostics Revenue Market Forecast (2019-2024)
• 12.6 South America Point-of-Care Molecular Diagnostics Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Point-of-Care Molecular Diagnostics Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology